← back to search

David A. Ostrov

University of Florida · US
Area of research
Pharmacology · Immunology
Research interest
Research interests include Drug-Induced Adverse Reactions, SARS-CoV-2 and COVID-19 Research, Immune Cell Function and Interaction, and Cell Adhesion Molecules Research.
h-index
50
citations
7,830
works
264
NIH funding
primary concept
Medicine
email

Recent publications

HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug Reactions
The Journal of Allergy and Clinical Immunology In Practice 2025cited by 3position: middledoi
Updates in SJS/TEN: collaboration, innovation, and community
Frontiers in Medicine 2023cited by 34position: middledoi
Asah2 Represses the p53–Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis
The Journal of Immunology 2021cited by 116position: middledoi
Generation of a Novel SARS-CoV-2 Sub-genomic RNA Due to the R203K/G204R Variant in Nucleocapsid: Homologous Recombination has Potential to Change SARS-CoV-2 at Both Protein and RNA Level
Pathogens and Immunity 2021cited by 67position: middledoi
Identification of antiviral antihistamines for COVID-19 repurposing
Biochemical and Biophysical Research Communications 2020cited by 113position: lastdoi
Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis
Nature Medicine 2019cited by 165position: middledoi
SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation
The Journal of Allergy and Clinical Immunology In Practice 2018cited by 177position: middledoi
Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy
Journal of Allergy and Clinical Immunology 2015cited by 61position: middledoi
Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity
PLoS ONE 2015cited by 12position: middledoi
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells
Blood 2013cited by 157position: middledoi
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
Proceedings of the National Academy of Sciences 2012cited by 417position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

S. Mallal · Tennessee Department of Health4 papers (2012–2021)John Sidney · La Jolla Institute for Immunology3 papers (2012–2021)Elizabeth J. Phillips · University of Manitoba3 papers (2012–2015)Amanda Wriston · University of Virginia2 papers (2012–2015)Andrew Lucas · The University of Western Australia2 papers (2012–2015)Søren Buus · University of Copenhagen2 papers (2012–2015)Alessandro Sette · University of California System2 papers (2012–2021)Donald F. Hunt · University of Virginia2 papers (2012–2015)Jeffrey Shabanowitz · University of Virginia2 papers (2012–2015)Bjoern Peters · La Jolla Institute for Immunology2 papers (2012–2015)John D. Klement · Augusta University1 papers (2021–2021) · 1 papers (2015–2015) · 1 papers (2021–2021)Arun Srivastava · University of Florida1 papers (2013–2013)Sarah Rowland‐Jones · Nuffield Orthopaedic Centre1 papers (2021–2021)Atul J. Butte · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2020–2020)Chunwan Lu · Tianjin University1 papers (2021–2021)Rohit Vashisht · Institute of Management Technology1 papers (2020–2020) · 1 papers (2015–2015)Aleena Banerji · Harvard University1 papers (2015–2015)